Select Funding Opportunities
Click here to visit the NCI grant site.
Use your device's search function to find a specific disease or funding source.
- External Funding
Funding
The Vera and Joseph Dresner Foundation
MDS Research Fund
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).
The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards
Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).
The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards
Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>
AACR Cancer Disparities Research Fellowship
The AACR Cancer Disparities Research Fellowship represents an effort to encourage and support postdoctoral or clinical research fellows to conduct cancer disparities research and to establish a successful career path in this field. The proposed research may be in basic, translational, clinical, or population sciences and must have direct applicability and relevance to cancer disparities.
Application Deadline: March 23, 2023
AACR Breast Cancer Research Fellowships
The AACR Breast Cancer Research Fellowships represent a joint effort to encourage and support postdoctoral or clinical research fellows to conduct breast cancer research and to establish a successful career path in this field. The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to breast cancer.
Application Deadline: March 23, 2023
Joint SPORE Developmental Research Program (DRP) Award – Cancer Disparities
The YCC Translational Research Office in collaboration with the Yale SPORE in Lung Cancer (YSILC) and the Yale Head and Neck SPORE (YHN-SPORE) have launched a new DRP award to provide support up to $50,000 for a translational pilot project focused on disparities-related cancer research in the field of Head and Neck and/or Lung cancer. Studies with a strong translational or clinical component that have the potential to evolve into, or be incorporated into, a full SPORE project and projects with multi-disciplinary collaborations and/or community-based participatory research studies are encouraged.
We encourage to submit your letter of intent (LOI) to anna.arnal@yale.edu
There is no deadline to apply, LOIs will we reviewed and eligible applicants will be invited to submit a full application online at: https://yale.infoready4.com/
Yale Head and Neck SPORE (YHN-SPORE) Career Enhancement Program (CEP)
The CEP of the Yale Head and Neck SPORE has been established to educate the next generation of investigators committed to translational research in head and neck cancer. The CEP will provide support to promising junior investigators and/or establish investigators who have not previously conducted head and neck cancer focused research.
Letter of Intent Due: Friday March 24, 2023
Yale Head and Neck SPORE (YHN-SPORE) Developmental Research Program (DRP)
The Yale Head and Neck SPORE’s DRP provides seed money to investigators to support studies with a strong translational component that have the potential to evolve into, or be incorporated as, a full YHN-SPORE project or to generate preliminary data or evidence of collaboration for other new NIH grant applications.
Letter of Intent Due: Friday March 24, 2023
The Chênevert Family Brain Tumor Center at Yale Developmental Research Awards
The Chênevert Family Brain Tumor Center at Yale is pleased to announce DEVELOPMENTAL RESEARCH AWARDS with first funding beginning 07/01/2023 to projects in amounts up to $100,000 over two years. The projects must focus on primary or metastatic brain tumors, and they must have a translational focus or high potential to lead to a translational project or a clinical trial.
Internal Submission Deadline: March 31, 2023
BCA Exceptional Project Grant
Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant. This award recognizes creative, unique and innovative research and is open to applicants at institutions throughout the contiguous United States.
Application Deadline: March 31, 2023
BCA Young Investigator Grant
To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for funding for the Young Investigator Grant. This grant is open to applicants at institutions throughout the contiguous United States. This is a two-year grant for a total of $125,000, with half the grant award being paid out each year.
Application Deadline: March 31, 2023
ACS Research Priority Area: Screening
Detecting cancer early saves lives. Unfortunately, the important benefits of cancer screening are not reaching enough people. The purpose of this RFA is to fund innovative research that will facilitate more widespread cancer screening and early detection culminating in reduced cancer mortality.
Internal Submission Deadline: April 3, 2023
HESI THRIVE Grant
A proud partner of the Biden Cancer Initiative, THRIVE provides seed grants for clinical and translational research and technology-based solutions that enhance our ability to predict when and how adverse effects may occur in patients who have received cancer treatment. THRIVE also supports the development of approaches to avoid or lessen these effects.
Letters of Intent Due: April 10, 2023
2023 Leslie H. Warner Postdoctoral Fellowships for Cancer Research
The Fellowships will support early-stage promising trainees that are conducting innovative basic, translational, clinical, or population-based cancer research with a Yale Cancer Center member. Relevance of proposed research to our catchment area priorities is also encouraged. Candidates may have up to one year of postdoctoral experience from the time of application.
Internal Submission Deadline: April 10, 2023
2024 Pew-Steward Scholars for Cancer Research
The Pew-Stewart Scholars for Cancer Research supports assistant professors of outstanding promise in science relevant to the advancement of a cure for cancer. For the 2024 award, one nomination will be invited from Yale University.
Internal Submission Deadline: April 10, 2023
DoD Ovarian Cancer Research Program Funding Opportunities 2023
The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer to enhance the health and well-being of Service Members, Veterans, their family members, and all women impacted by this disease.
Investigator-Initiated Research Award- Pre-proposal due: April 17, 2023
https://cdmrp.health.mil/funding/pa/HT9425-23-OCRP-IIRA_GG.pdf
Ovarian Cancer Academy Award- Early-Career Investigator- Pre-proposal due: April 17, 2023
https://cdmrp.health.mil/funding/pa/HT9425-23-OCRP-OCA-ECI_GG.pdf
Pilot Award- Pre-proposal due: April 17, 2023
Diversity Enhancement Program in Oncology at Yale Cancer Center
The Diversity Enhancement Program in Oncology is an initiative established by the Section of Medical Oncology at YCC. The Program is designed to foster underrepresented in medicine (URiM) trainees’ interest in careers in hematology/medical oncology (heme/onc) and to build a pipeline to bring URiM candidates to the YCC Heme/Onc Fellowship Program and YCC-Advanced T32 Training Program for Physician-Scientists.
The Diversity Enhancement Program in Oncology supports 2 URiM medical students or residents to spend an 8-week oncology rotation at Yale in summer 2023. The rotation will include an oncology clinical experience in conjunction with a clinical or translational research project. The selected medical student(s) or resident(s) will be mentored by YCC faculty and co-mentored by Heme/Onc T32 Fellows. The Section of Medical Oncology at YCC will cover the expenses including living, transportation, and research for up to $5,000 per person.
Application Deadline: April 19, 2023
Yale SPORE in Lung Cancer Career Enhancement Program (CEP)
The CEP of the Yale SPORE in Lung Cancer has been established to educate the next generation of investigators committed to translational research in lung cancer. The CEP will provide support of up to $50,000 to promising junior investigators and/or establish investigators who have not previously conducted lung cancer focused research.
Letters of Intent Due: April 21, 2023
Yale SPORE in Lung Cancer Developmental Research Program (DRP) Award
The DRP of the Yale SPORE in Lung Cancer provides seed money to investigators to support studies with a strong translational component that have the potential to evolve into, or be incorporated as, a full Yale SPORE in Lung Cancer project. The purpose is also to generate preliminary data or evidence of collaboration for new NCI grant applications.
Letters of Due: April 21, 2023
Biomedical Knowledgebase (U24)
This FOA is designed to support biomedical knowledge bases. Biomedical knowledge bases under this announcement should have the primary function to extract, accumulate, organize, annotate, and link growing bodies of information related to core datasets.
Application Deadline: May 8, 2023
Biomedical Data Repository (U24)
This FOA is designed to support biomedical data repositories. Biomedical data repositories under this announcement should have the primary function to ingest, archive, preserve, manage, distribute, and make accessible the data related to a particular system or systems.
Application Deadline: May 8, 2023
Robert A. Winn Diversity in Clinical Trials Award Program
The goal of the Robert A. Winn Career Development Award (Winn CDA) is to increase the diversity of patients enrolled in clinical trials, and ultimately to enhance the development of therapeutics for all populations.
Application Deadline: May 12, 2023
LCRF Minority Career Development Award (CDA) in Lung Cancer
Minority applicants are less likely to receive grants, to have the R phases of K01 or K99 awards activated, need more submissions to obtain funding, and often will not resubmit proposals. As minority applicants must overcome systemic and structural barriers due to race, ethnicity, country of origin, socioeconomic status, and/or language, many leave academia which further exacerbates the lack of diversity in Science, Technology, Engineering and Mathematics (STEM) and medical fields. To provide protected time and mentoring to these trainees, we continue to offer the LCRF Minority Career Development Award (CDA) for Lung Cancer for minority postdoctoral/clinical fellows and assistant professors within 10 years of completing their MD and/or PhD degrees to submit proposals.
Application Deadline: May 31, 2023
Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01/R21)
Through this FOA, the NCI intends to focus on the biological interactions of cancer health disparities in people living with HIV (PLWH) from underrepresented minority groups through basic mechanistic or translational studies to investigate how HIV interacts with health disparities to promote both non-AIDS and AIDS-defining cancer initiation, progression, and the resulting pathogenic disease sequelae.
Application Deadline: December 15, 2023
NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01)
This Funding Opportunity Announcement (FOA) supports the Cancer Moonshot Scholars Diversity Program (CMSDP) and solicits R01 grant applications that propose independent research projects within the scientific mission of the National Cancer Institute (NCI). The overarching goal of the CMSDP is to increase the number of R01 Early Stage Investigators (ESIs) and enhance the diversity of the cancer research workforce, while promoting scientific advancements in cancer. Investigators from diverse backgrounds, including those from underrepresented groups are encouraged to work with their institutions to apply.
Application Deadline: February 6, 2024